Ongoing Surveillance During Treatment Once peptide therapy is initiated, ongoing surveillance for malignancy should continue throughout the treatment period and potentially beyond, depending on treatment duration and individual risk factors
The lack of regulation in these markets raises concerns about the authenticity and purity of the peptide
This is the standard trial design for injectable peptides
That's what MAHA is, said Gary Brecka, a longevity influencer who gave testimony at the hearing
The format provides rapid action, shortens rehabilitation time, and maintains high functional tissue performance.
Doctors are using a regulatory gap to prescribe an unauthorized peptide Experts urge authorities to close loophole Despite Health Canada's warnings against the use of unauthorized peptides as a health and fitness shortcut, a CBC News investigation uncovered doctors using a regulatory loophole to prescribe one of the unproven products to patients